QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study.
Matteo MegnaMaria FerrilloRuggiero AngeloEleonora CinelliLucia GalloGabriella FabbrociniPublished in: International journal of dermatology (2020)
Annual TB screening is important in psoriasis patients under biologic treatment in order to avoid possible latent TB infection reactivation. Indeed, our data showed that even in a low TB prevalence country like Italy, QFT may convert over time in psoriasis patients under biologics in 6.5% of the cases.